Aging regulates 5-HT1B receptors and serotonin reuptake sites in the SCN

被引:23
作者
Duncan, MJ [1 ]
Crafton, CJ [1 ]
Wheeler, DL [1 ]
机构
[1] Univ Kentucky, Med Ctr, Dept Anat & Neurobiol, Lexington, KY 40536 USA
关键词
suprachiasmatic nucleus; aging; 5-HT1B receptors; serotonin transporter; circadian rhythms; hamster;
D O I
10.1016/S0006-8993(99)02397-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Middle age is associated with changes in circadian rhythms (e.g., alterations in the timing of the circadian wheel running rhythm) which resemble changes induced by selective destruction of the serotonergic input to the suprachiasmatic nucleus (SCN), the principal mammalian circadian pacemaker. We hypothesized that serotonergic neurotransmission in the SCN is decreased in middle-aged hamsters, as compared to young adults. This hypothesis was tested indirectly by investigating the effect of aging on two markers of serotonin neurotransmission, 5-HT1B receptors and serotonin reuptake sites, which are regulated by serotonin. Previous studies have shown that experimentally induced decreases in serotonergic neurotransmission increase 5-HT1B receptors but decrease serotonin reuptake sites. Quantitative autoradiography was conducted using [I-125]iodocyanopindolol ([I-125]ICYP) and [H-3]paroxetine, selective radioligands for the 5-HT1B receptors and the serotonin reuptake sites, respectively. Consistent with the hypothesis, specific ([I-125]ICYP binding was significantly elevated in the SCN of middle-aged hamsters, as compared to young hamsters. The results also showed that serotonin reuptake sites in the SCN were significantly increased in both middle-aged and old hamsters, as compared to young controls. This result could not have been caused by decreased serotonin release. Alternatively, increased serotonin reuptake, which would reduce serotonin levels in the synaptic cleft, may cause or contribute to the increase in 5-HT1B receptor binding in the SCN in middle aged animals. These results show that the SCN exhibits changes in serotonergic function during middle age, which has been characterized by changes in the expression of circadian rhythms. Because these changes occur during middle age, they probably reflect the aging process, rather than senescence or disease. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:213 / 219
页数:7
相关论文
共 45 条
[1]   THE MOUSE 5-HYDROXYTRYPTAMINE(1B) RECEPTOR IS LOCALIZED PREDOMINANTLY ON AXON TERMINALS [J].
BOSCHERT, U ;
AMARA, DA ;
SEGU, L ;
HEN, R .
NEUROSCIENCE, 1994, 58 (01) :167-182
[2]   EFFECTS OF THE 5-HT1A RECEPTOR AGONIST 8-OH-DPAT AND OTHER NON-PHOTIC STIMULI ON THE CIRCADIAN-RHYTHM OF WHEEL-RUNNING ACTIVITY IN HAMSTERS UNDER DIFFERENT CONSTANT CONDITIONS [J].
CUTRERA, RA ;
OUAROUR, A ;
PEVET, P .
NEUROSCIENCE LETTERS, 1994, 172 (1-2) :27-30
[3]   SPECIFIC DESTRUCTION OF THE SEROTONERGIC AFFERENTS TO THE SUPRACHIASMATIC NUCLEI PREVENTS TRIAZOLAM-INDUCED PHASE ADVANCES OF HAMSTER ACTIVITY RHYTHMS [J].
CUTRERA, RA ;
KALSBEEK, A ;
PEVET, P .
BEHAVIOURAL BRAIN RESEARCH, 1994, 62 (01) :21-28
[4]  
Davis FC, 1998, AM J PHYSIOL-REG I, V275, pR960
[5]  
Dudley TE, 1998, J NEUROSCI, V18, P5045
[6]   Comparison of the effects of aging on 5-HT7 and 5-HT1A receptors in discrete regions of the circadian timing system in hamsters [J].
Duncan, MJ ;
Short, J ;
Wheeler, DL .
BRAIN RESEARCH, 1999, 829 (1-2) :39-45
[7]   INVESTIGATIONS OF THE REGULATION OF SPECIFIC 2-[I-125]IODOMELATONIN BINDING-SITES IN SIBERIAN HAMSTERS BY ENDOGENOUS AND EXOGENOUS MELATONIN [J].
DUNCAN, MJ ;
HELLER, KS ;
PURVIS, CC ;
MASSEY, BT ;
STETSON, MH .
BRAIN RESEARCH, 1993, 631 (01) :107-113
[8]   SEROTONIN AND THE MAMMALIAN CIRCADIAN SYSTEM .2. PHASE-SHIFTING RAT BEHAVIORAL RHYTHMS WITH SEROTONERGIC AGONISTS [J].
EDGAR, DM ;
MILLER, JD ;
PROSSER, RA ;
DEAN, RR ;
DEMENT, WC .
JOURNAL OF BIOLOGICAL RHYTHMS, 1993, 8 (01) :17-31
[9]   ALTERATIONS OF SEROTONIN RECEPTOR-BINDING IN THE HYPOTHALAMUS FOLLOWING ACUTE DENERVATION [J].
FRANKFURT, M ;
MENDELSON, SD ;
MCKITTRICK, CR ;
MCEWEN, BS .
BRAIN RESEARCH, 1993, 601 (1-2) :349-352
[10]  
HOYER D, 1985, EUR J PHARMACOL, V118, P12